Tartu \u00dclikooli ja tervisetehnoloogia ettev\u00f5tte Antegenes juhitud Bright projektiga loodud rinnav\u00e4hi ennetuse ja s\u00f5eluuringu teenus p\u00e4lvis Euroopa innovatsiooni- ja tehnoloogiainstituudi (EIT) teise koha auhinna, kui \u00fcks Euroopa silmapaistvam tervisetehnoloogia uuendus, kirjutab BNS.<\/p>\n
Projekti k\u00e4igus t\u00f6\u00f6tati v\u00e4lja geneetiliste riskide hindamisel p\u00f5hinev mudel, mille toimivust testiti rakendusuuringutes Eestis, Portugalis ja Rootsis. Uuringutes hinnati nii teenuse kliinilist kasulikkust ja kulut\u00f5husust kui ka selle sobivust erinevatele tervishoius\u00fcsteemidele.<\/p>\n
Projekti juht, Tartu \u00fclikooli meditsiinigeneetika professor Neeme T\u00f5nisson \u00fctles, et innovatsiooni fookuses oli nooremate naiste h\u00f5lmamine rinnav\u00e4hi ennetusse. \u201eSeadsime eesm\u00e4rgiks lahendada k\u00fcsimus, kuidas laiendada s\u00f5eluuringut naistele enne tavap\u00e4rast s\u00f5eluuringuiga, v\u00e4ltides samal ajal \u00fclediagnoosimist ning hoides tasakaalus kasu ja kulud. Riskip\u00f5hine s\u00f5eluuring on selleks k\u00f5ige t\u00f5husam viis. Kui tuvastame k\u00f5rgenenud v\u00e4hiriskiga naised varem, on just neile oluline pakkuda s\u00f5eluuringut nooremas vanuses kui t\u00e4nane standard seda ette n\u00e4eb,\u201c s\u00f5nas T\u00f5nisson.<\/p>\n
Antegenesi tegevjuht, onkoloog Peeter Padrik \u00fctles, et uue p\u00f5lvkonna s\u00f5eluuring peabki l\u00e4henema erinevatele naistele nende riske arvestades, eesm\u00e4rgiga avastada v\u00e4hk varakult ning samal ajal toetades tervisek\u00e4itumist, et v\u00e4hendada haigestumise t\u00f5en\u00e4osust. \u201cT\u00e4htis on ka see, et oleme loonud teenuse, mis on patsiendile mugav. Telemeditsiin ja kodutestimine v\u00f5imaldavad teenust kasutada ka ilma tervishoiuasutusse minemata,\u201d lausus Padrik.<\/p>\n
Rinnav\u00e4hi personaliseeritud ennetus \u00fchendab pol\u00fcgeense riski testimise, perekondliku v\u00e4hianamneesi hindamise ning vajadusel k\u00f5rge riskiga geenivariantide testimise. Nende alusel luuakse naisele personaalne ennetusplaan, mis annab soovitused, millises vanuses ja kuidas teha s\u00f5eluuringut. Bright projekti tulemused n\u00e4itasid, et 15 rinnav\u00e4hist tingitud surmajuhtumit on v\u00f5imalik kulut\u00f5husalt \u00e4ra hoida iga 10 000 personaliseeritud ennetusse kaasatud naise kohta.<\/p>\n
Teenust on rakendatud Eesti, Suurbritannia, Saksamaa, Leedu ja Bulgaaria tervishoiu erasektoris, samuti rakendamisel Portugalis.<\/p>\n","protected":false},"excerpt":{"rendered":"Tartu \u00dclikooli ja tervisetehnoloogia ettev\u00f5tte Antegenes juhitud Bright projektiga loodud rinnav\u00e4hi ennetuse ja s\u00f5eluuringu teenus p\u00e4lvis Euroopa innovatsiooni-…\n","protected":false},"author":2,"featured_media":52522,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[80],"tags":[2838,13363,26,27,37,33,35,15863,34,36,31,32,21,28,29,95,19,25,8333,26695,7740,23,24,22,20,294,30,92,93,94],"class_list":{"0":"post-52521","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-maailm","8":"tag-analuus","9":"tag-auhind","10":"tag-breaking-news","11":"tag-breakingnews","12":"tag-ee","13":"tag-eesti","14":"tag-eesti-keel","15":"tag-ennetus","16":"tag-estonia","17":"tag-estonian","18":"tag-featured-news","19":"tag-featurednews","20":"tag-headlines","21":"tag-latest-news","22":"tag-latestnews","23":"tag-maailm","24":"tag-news","25":"tag-populaarseimad-lood","26":"tag-rinnavahk","27":"tag-skriining","28":"tag-soeluuring","29":"tag-top-stories","30":"tag-topstories","31":"tag-uldised-uudised","32":"tag-uudised","33":"tag-uuring","34":"tag-viimased-uudised","35":"tag-world","36":"tag-world-news","37":"tag-worldnews"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@ee\/115626895197374252","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/ee\/wp-json\/wp\/v2\/posts\/52521","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/ee\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/ee\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ee\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ee\/wp-json\/wp\/v2\/comments?post=52521"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/ee\/wp-json\/wp\/v2\/posts\/52521\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ee\/wp-json\/wp\/v2\/media\/52522"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/ee\/wp-json\/wp\/v2\/media?parent=52521"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/ee\/wp-json\/wp\/v2\/categories?post=52521"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/ee\/wp-json\/wp\/v2\/tags?post=52521"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}